NEWS
News Articles
GeoVax Labs updates investors on its COVID-19 vaccine and cancer immunotherapy clinical trials
GeoVax Labs CEO David Dodd talks to Proactive about its three separate ongoing Phase II clinical trials in developing a COVID-19 booster to mRNA vaccines, a COVID-19 vaccine to immunocompromised patients, and and a cancer immunotherapy for advanced head and neck cancer. Dodd says each are progressing well, and he says, the company is currently…
Read MoreScience Hill funding approved by Georgia General Assembly
Several UGA projects received financial support from Georgia lawmakers this session During the recent 2022 legislative session, state lawmakers voted to support the University of Georgia’s growing research enterprise by investing close to $49 million to complete the renovation of 186,000 square feet of laboratory space on a section of campus called Science Hill. The ongoing…
Read MoreCambium Co-Founders Receive “Start-Up of the Year” Award From Emory University’s Office of Tech Transfer
Approval in 2021 to begin Phase III studies on Elate Ocular® Biologic for Dry Eye Major Milestone Supporting Award Cambium Medical Technologies, a clinical stage company developing novel processed allogeneic platelets for therapeutic applications, announced today two co-founders were awarded “Start-Up of the Year” by Emory University’s Office of Technology Transfer. The award was one of…
Read MoreFour Emory professors named to American Academy of Arts and Sciences
Four Emory University faculty members have been elected to the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies and a leading center for independent policy research. Elected this year are: Carlos del Rio, MD, executive associate dean, Emory School of Medicine & Grady Health System; Leon L.…
Read MoreGeorgia Tech’s Paul Joseph Awarded Fulbright Specialist Grant to India
Paul Joseph, a principal research scientist in the Institute for Electronics and Nanotechnology (IEN) at Georgia Tech, has received a Fulbright Specialist Award to India from the Fulbright Foreign Scholarship Board. Joseph will spend two weeks at the Indian Institute of Information technology (IIIT) this summer helping to expand the nanotechnology curriculum and assisting with…
Read MoreSaol Therapeutics Announces First Patient Dosed in Phase 2 RAISE Spasticity Trial Evaluating the Safety Profile of SL-1002 for Limb Spasticity
Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the first patient has been enrolled in the company’s Phase 2 RAISE Spasticity Trial. SL-1002 is a novel, proprietary, nerve-blocking agent currently under development at Saol Therapeutics and is being evaluated in the RAISE Spasticity Trial. The trial is a double-blind, placebo-controlled, single ascending-dose…
Read More